Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
Biological Psychiatry|December 25, 2012
Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and functionJason M Hodge, Yiming Wang, Michael Berk, et al.
Translational Vision Science & Technology|September 25, 2020
Edge of Scotoma Sensitivity as a Microperimetry Clinical Trial End Point in USH2A RetinopathyJason Charng, Tina M Lamey, Jennifer A Thompson, et al.
Cornea|September 26, 2003
AlphaCor cases: comparative outcomesCelia R Hicks, Geoffrey J Crawford, Donald T Tan, et al.
Retina (Philadelphia, Pa.)|March 28, 2022
SIBLING CONCORDANCE IN SYMPTOM ONSET AND ATROPHY GROWTH RATES IN STARGARDT DISEASE USING ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCERachael C Heath Jeffery, Jennifer A Thompson, Johnny Lo, et al.
Ophthalmology Science|October 17, 2022
Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus AutofluorescenceRachael C Heath Jeffery, Jennifer A Thompson, Johnny Lo, et al.
The British Journal of Ophthalmology|April 16, 1998
Clinical results of implantation of the Chirila keratoprosthesis in rabbitsC R Hicks, T V Chirila, A B Clayton, et al.
Lancet (London, England)|October 4, 2015
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trialElizabeth P Rakoczy, Chooi-May Lai, Aaron L Magno, et al.
Ebiomedicine|November 21, 2016
Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular DegenerationIan J Constable, Cora M Pierce, Chooi-May Lai, et al.
The British Journal of Ophthalmology|June 21, 2005
Generation of transgenic mice with mild and severe retinal neovascularisationC-M Lai, S A Dunlop, L A May, et al.
Scientific Reports|June 1, 2016
Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degenerationGabriel Cuellar-Partida, Jamie E Craig, Kathryn P Burdon, et al.
Pageof 28